DGAP

DGAP-News: FUCHS PETROLUB announces personnel changes in the Supervisory Board for 2022

Retrieved on: 
Wednesday, January 19, 2022 - 8:26pm

FUCHS develops, produces and markets high-grade lubricants and related specialties for virtually all industries and areas of application.

Key Points: 
  • FUCHS develops, produces and markets high-grade lubricants and related specialties for virtually all industries and areas of application.
  • The company, which was founded in Mannheim in 1931, employs around 6,000 people worldwide at 58 operating companies.
  • This press release contains future-oriented statements, which are based on assumptions and estimates by the corporate management of FUCHS PETROLUB SE.
  • FUCHS PETROLUB SE accepts no guarantee or liability for the future development and the actual results achieved in future matching the assumptions and estimates expressed in this press release.

DGAP-News: CompuGroup Medical expects continued strong organic growth in 2022 and first step towards higher margins

Retrieved on: 
Wednesday, January 19, 2022 - 8:26pm

The mandatory regulatory updates to our products have been delivered in time before the end of the year.

Key Points: 
  • The mandatory regulatory updates to our products have been delivered in time before the end of the year.
  • With the preliminary results now expected to be published in early March CompuGroup Medical reconfirms its guidance today for the financial year 2021.
  • Based on currently available data and the expectations of business performance for the year, CompuGroup Medical expects another year with strong organic growth, driven by the investment initiative started last year.
  • About CompuGroup Medical SE & Co. KGaA
    CompuGroup Medical is one of the leading e-health companies in the world.

DGAP-News: Evotec and Lilly enter into drug discovery collaboration in metabolic diseases

Retrieved on: 
Wednesday, January 19, 2022 - 8:26pm

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that the Company has entered into a drug discovery collaboration with Eli Lilly and Company ("Lilly") in the field of metabolic diseases with a focus on kidney diseases and diabetes.

Key Points: 
  • Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that the Company has entered into a drug discovery collaboration with Eli Lilly and Company ("Lilly") in the field of metabolic diseases with a focus on kidney diseases and diabetes.
  • Evotec will be responsible for the discovery of potential drug candidates for the treatment of diabetes and chronic kidney diseases from targets identified by Lilly or by Evotec.
  • Dr Cord Dohrmann, Chief Scientific Officer of Evotec, commented: "We are excited to enter into this research partnership with Lilly.
  • Evotec's patient-derived molecular data in combination with our omics-supported multimodality drug discovery platform delivers highest quality drug candidates for our partners.

DGAP-News: Corestate strengthens institutional real estate business: Martin Eberhardt joins as new CIO for DACH region, Edward Bates becomes CIO International

Retrieved on: 
Wednesday, January 19, 2022 - 8:26pm

The company sees itself as a manager for the entire length of the real estate value chain.

Key Points: 
  • The company sees itself as a manager for the entire length of the real estate value chain.
  • The consistent focus on asset classes that will be successful in the long run constitutes a central cornerstone of the company strategy.
  • At CORESTATE, all concepts are supported with ESG expertise that is unique to the industry.
  • With some 850 experts, CORESTATE offers clients and investors a full range of services and consultation from a single source, from project financing and real estate management to sales.

DGAP-News: SUNfarming acquires further projects in Poland

Retrieved on: 
Wednesday, January 19, 2022 - 8:25pm

The total of 48 solar projects were acquired from various Polish developers, some of whom SUNfarming has already worked with in the past.

Key Points: 
  • The total of 48 solar projects were acquired from various Polish developers, some of whom SUNfarming has already worked with in the past.
  • 37 MWp, for its construction financing SUNfarming was able to gain a new financing partner with the help of Capcora.
  • SUNfarming acquired further ready-to-build photovoltaic projects with secured tariffs in December 2021 - the largest portfolio with 37 MWp consists of 39 individual projects that secured a "Contract for Difference" (CfD) in the auction in June 2021.
  • SUNfarming has already been able to secure the construction phase financing for all projects in order to ensure that the projects can be implemented in a timely manner.

DGAP-News: SHOP APOTHEKE EUROPE Expands in Italy with New Logistics Centre.

Retrieved on: 
Wednesday, January 19, 2022 - 8:25pm

SHOP APOTHEKE EUROPE Expands in Italy with New Logistics Centre.

Key Points: 
  • SHOP APOTHEKE EUROPE Expands in Italy with New Logistics Centre.
  • SHOP APOTHEKE EUROPE just signed the contract for a new logistics centre in Italy.
  • Expanding the logistics capacities in Italy will enable SHOP APOTHEKE EUROPE to optimally leverage the potential of Italian customer demand, have faster delivery times and grow its local business.
  • SHOP APOTHEKE EUROPE is currently recruiting staff in Italy for several office and warehouse positions under the leadership of Massimiliano Grigolini, Director, Country Management Italy & Switzerland.

DGAP-News: FIRST HYDROGEN APPOINTS GILL AS CEO OF AUTOMOTIVE DIVISION

Retrieved on: 
Wednesday, January 19, 2022 - 8:25pm

Cautionary Note Regarding Forward-Looking Statements This news release contains information or statements that constitute "forward-looking statements."

Key Points: 
  • Cautionary Note Regarding Forward-Looking Statements This news release contains information or statements that constitute "forward-looking statements."
  • Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date.
  • First Hydrogen undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.
  • The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

DGAP-News: Aurubis AG: Aurubis AG exceeds expectations for Q1 and increases full-year forecast

Retrieved on: 
Wednesday, January 19, 2022 - 8:24pm

Hamburg, January 19, 2022 - Aurubis AG exceeds the market expectations for Q1 of its 2021/22 fiscal year, which ended on December 31, 2021: according to preliminary figures, the multimetal company generated operating earnings before taxes (EBT) of 152 million for Q1 (previous year: 82 million).

Key Points: 
  • Hamburg, January 19, 2022 - Aurubis AG exceeds the market expectations for Q1 of its 2021/22 fiscal year, which ended on December 31, 2021: according to preliminary figures, the multimetal company generated operating earnings before taxes (EBT) of 152 million for Q1 (previous year: 82 million).
  • The forecast range for operating EBT was previously between 320 million and 380 million.
  • "In the first quarter of its current fiscal year, too, Aurubis demonstrated a very good operating performance at the sites of its smelter network.
  • Aurubis AG is a leading global provider of non-ferrous metals and one of the largest copper recyclers worldwide.

DGAP-News: DATAMETREX REPORTS $20M IN CASH ON THE BALANCE SHEET FROM OPERATION

Retrieved on: 
Wednesday, January 19, 2022 - 8:24pm

Toronto, Canada, January 18, 2022 - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the "Company" or "Datametrex") is pleased to announce that the Company currently has approximately $20M in cash and cash equivalent (marketable securities) on the balance sheet.

Key Points: 
  • Toronto, Canada, January 18, 2022 - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the "Company" or "Datametrex") is pleased to announce that the Company currently has approximately $20M in cash and cash equivalent (marketable securities) on the balance sheet.
  • Over the last few quarters, the Company has had strong positive cash flow from its operations, which is attributed to the current strong balance sheet.
  • The cash balance is twenty times what it was valued in the same period of 2019.
  • Datametrex believes there will be continuous growth in revenue and profitability from its operations, which will generate stronger positive cash flow for the Company in 2022, resulting in a stronger balance sheet and cash position.

DGAP-News: alstria office REIT-AG: Strong leasing results in Ratingen and Essen

Retrieved on: 
Wednesday, January 19, 2022 - 8:23pm

alstria office REIT AG is the leading real-estate operator focusing solely on German office property in selected German markets.

Key Points: 
  • alstria office REIT AG is the leading real-estate operator focusing solely on German office property in selected German markets.
  • alstria strives for sustainable long-term value creation while taking advantage of short-term arbitrage of inefficiencies in the real estate markets.
  • This release constitutes neither an offer to sell nor a solicitation of an offer to buy any shares.
  • As far as this press release contains forward-looking statements with respect to the business, financial condition and results of operations of alstria office REIT-AG (alstria), these statements are based on current expectations or beliefs of alstria's management.